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Objective: To determine whether differences in synovial ﬂuid (SF) biomarkers of collagen and proteo-
glycan turnover are associated with pre-radiographic damage to articular cartilage and menisci following
anterior cruciate ligament (ACL) injury and are of clinical value.
Method: SF samples from ACL injured knees of 108 patients were obtained when damage to cartilages
and menisci was evaluated arthroscopically. Concentrations of SF collagenase-generated cleavage neo-
epitope of type II collagen (C2C) were determined using ELISA and aggrecan-derived disaccharides of
chondroitin-4-sulfate (Ddi-C4S), chondroitin-6-sulfate (Ddi-C6S), and keratan sulfate (KS), were
measured in SF by High performance liquid chromatography (HPLC).
Results: Radiographic examination failed to detect any intra-articular degenerative changes. The number
of high-grade cartilage lesions was positively associated with age, duration after injury and the level of
C2C, and negatively with the level of KS. There was no association between the number of high-grade
cartilage and meniscal lesions. Multivariable logistic regression revealed signiﬁcant associations of
increased C2C (adjusted Odds ratio (OR) of the upper quartile to remainder of 2.49, 95% Conﬁdence
interval (CI) ¼ 0.85e7.27) and decreased KS (adjusted OR of the lower quartile to the remainder of 3.32,
95% CI ¼ 1.19e9.24) with the presence of three or more high-grade cartilage lesions, independent of age
and duration after injury. The combined impact of increased C2C and decreased KS was 22.8 (95%
CI ¼ 1.95e265.9), far exceeding the impact of each independent biomarker.
Conclusion: Combinations of the C2C and KS as described here may offer greater ability to identify pa-
tients with early pre-radiographic high-grade cartilage damage compared to single clinical or biomarker
parameters.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The principle components of articular cartilage by mass are the
proteoglycan aggrecan and type II collagen present in the extra-
cellular matrix. Collagen ﬁbrils provide tensile strength to maintain
tissue integrity whereas aggrecan, interwoven with the collagen: T. Kojima, Department of
dicine, 65 Tsurumai, Showa,
Fax: 81-52-744-2260.
ima).
s Research Society International. Pﬁbrils, contributes to the compressive stiffness. The destruction of
articular cartilage is a characteristic feature of osteoarthritis (OA)1.
Therefore, it is important to detect early damage of articular
cartilage in order to prevent the development of OA.
Evaluation of early cartilage damage is difﬁcult. In many cases,
patients seek medical care only after developing symptoms. At that
time, theyoftenhave advancedOAwithextensivedamage to articular
cartilages, which are detectable radiographically. Morphologically,
conventional radiographic examination lacks sufﬁcient sensitivity to
detect early cartilage damage. Magnetic Resonance Imaging (MRI) is
very useful here but is expensive and often not readily available.ublished by Elsevier Ltd. All rights reserved.
H. Yoshida et al. / Osteoarthritis and Cartilage 21 (2013) 831e838832The destruction of joint cartilage matrix associated with early
focal lesions and OA involves the degradation and increased turn-
over of these matrix molecules, such as type II collagen and pro-
teoglycan. This results in the release of molecular degradation
products into joint ﬂuid, sera and sometimes urine. Quantitative
analyses of these degradation products in body ﬂuids potentially
offer an attractive way of detecting and assessing pathologic
changes in articular cartilage in OA. In recent years, many
biochemical/molecular markers have been tested with the aim of
developing new tools for the early detection andmonitoring of OA2.
As for the proteoglycan aggrecan, changes in the proteoglycan
glycosaminoglycans chondroitin sulfate3 and keratan sulfate (KS)4
reﬂect altered joint cartilage metabolism in normal and arthritic
states. Increased concentrations of aggrecan and proteoglycan
fragments, matrix metalloproteinases and their inhibitors in sy-
novial ﬂuid (SF) after joint injury and in OA development have been
reported5e7.
Increased collagenase cleavage and denaturation of type II
collagen by collagenases are commonly observed in articular car-
tilages of patients who have suffered joint injury, or have early focal
lesions8e10 or have developed OA11,12. Collagenase-generated
cleavage products of type II collagen can be detected by the C2C
immunoassay in normal sera13,14. These are increased in content in
sera and urines of patients with arthritis13,15, and in SF in animal
models16. Measurement of the crosslinked C-telopeptide from type
II collagen (CTX-II) in SF of the injured knee can also detect early
changes in cartilage turnover following joint injury and in OA17. The
changes observed in these earlier human studies of SF biomarkers
were related to events following joint injury and/or the presence of
OA. However, it is still unclear whether biomarker differences are
related to the actual damage to articular cartilages and/or menisci
that might be present following the joint injury.
It is well known that patients with anterior cruciate ligament
(ACL) deﬁciency are at an increased risk for the development of
OA18. According to a recent systematic review, the prevalence of
knee OA was low in individuals with isolated ACL injury (0e13%)
and high in subjects with combined injuries (21e48%). The most
frequently reported risk factor for the development of knee OA is
meniscal injury19.
The aim of this study was to determine whether there is an
association between biomarkers measured in SFs and damage to
articular cartilages and/or menisci. Such a relationship may have
important clinical value in helping detect early damage to these
joint tissues. We examined knee joints arthroscopically in the
period following ACL injury and before the development of radio-
graphic changes. The following biomarkers were studied in SFs:
cartilage type II collagen collagenase-generated cleavage neo-
epitope (C2C biomarker assay) and disaccharides of the glycos-
aminoglycans chondroitin sulfate and KS that are mainly present in
articular cartilages on the proteoglycan aggrecan. We also exam-
ined the inﬂuence of age, gender, duration after injury andmeniscal
injury on these biomarkers and joint damage.
Patients and methods
Patients
Patients with ACL injury who underwent knee examinations in
Mitsubishi Nagoya Hospital (Nagoya, Japan) and Kasugai Orthope-
dic Hospital (Kasugai, Japan) during the period between January
2001 and March 2003 were invited to join the study. All patients
agreed and provided written informed consents before SF collec-
tion. SF from each participant was obtained at arthroscopy imme-
diately prior to ACL reconstruction of the knee. Patients’ age, gender
and time after joint injury were also recorded. The study protocolwas approved by the institutional review boards of all participating
hospitals. We excluded patients who had insufﬁcient volume (at
least 500 ml required) of SF for biomarker assays.
Arthroscopic evaluation of articular cartilages and menisci
In addition to standing anterior/posterior and lateral view
radiographic examinations of patients’ injured knees, arthroscopic
evaluations were performed during the same procedure on each
injured knee by three senior doctors before surgery.
Cartilage degeneration was evaluated using the Outerbridge
grading system20. It assesses both depth and size of the macro-
scopic chondropathic changes involving the articular cartilage
surface, ranging from Grade 0 to IV. Grade 0 indicates normal.
Grade I is characterized by softening and swelling of the cartilage.
Grade II reﬂects the presence of macroscopically observable frag-
mentation and ﬁssuring in an area half an inch or less in diameter.
Grade III represents fragmentation and ﬁssuring that occupies an
area more than half an inch in diameter. Grade IV is characterized
by erosion of cartilage with eburnation of bone. The average of the
three evaluators’ grading was recorded.
Cartilage lesions were independently evaluated on six articular
surfaces, namely the patella, femoral groove, lateral femoral
condyle (LFC), medial femoral condyle (MFC), lateral tibial plateau
(LTP), and medial tibial plateau (MTP) (Fig. 1). We deﬁned Grade II
or higher as high-grade damage and determined the total for each
patient. In view of the importance of the distinction between
grades I and II, the inter-observer error was determined and found
to be 9.1%.
We also recorded any damage to menisci (degree of tear; com-
plete or incomplete, type of tear; bucket handle, ﬂap). Only patients
with complete tears underwent additional meniscal surgery. We
deﬁned a complete tear as a high-grade meniscal lesion and
determined the total for each patient.
Radiographic examination
Knee radiographs were examined and graded by author HY
using the KellgreneLawrence grading system21 without knowing
any other clinical information. Additionally, the presence of sub-
chondral cystic and sclerotic bone lesions was also recorded.
Sampling of SF
Sampling was performed with an 18 gauge needle and syringe
immediately prior to arthroscopy using a lateral suprapatellar
approach. Samples were transferred into plastic tubes and centri-
fuged at 10,000 rpm for 20 min at 4C. The cell-free supernatants
were stored at 80C until analyzed. The biochemical analyses
described below were performed blinded with respect to the
arthroscopic evaluations.
Measurement of C2C cartilage collagen cleavage neoepitope
An assay was used which speciﬁcally measures cartilage type II
collagen cleavage by collagenases (C2C assay). This assay, which is
also commercially available (IBEX, Montreal, Canada), has been
used in clinical studies of aging, menopause and joint damage13,14.
The characterization of the assay, including speciﬁcity and repro-
ducibility, has been described elsewhere in detail13. The intra-assay
coefﬁcient of variation was <5% and the inter-assay coefﬁcient of
variation was <13%. The assay performance is otherwise as
described previously14.
To reduce its viscosity and facilitate accurate pipetting SF was
ﬁrst digested overnight at 37C with 0.4 turbidity-reducing units/
Fig. 1. Arthroscopic evaluation of grades of cartilage lesions and meniscus damage in patients with ACL rupture. Arthroscopic evaluations graded the six articular surfaces
shown independently according to the Outerbridge scoring. Low grade represents cartilage Outerbridge Grade 0 and I, high-grade is Outerbridge Grade IIeIV. Meniscus damage was
demonstrated as no damage, incomplete tear, and complete tear. The numbers and percentage (latter shown in brackets) indicate the patients in that category.
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10 mM sodium acetate, pH 5.0, with a cocktail of proteinase in-
hibitors (1 mM EDTA, 1 mM phenylmethylsulfonyl ﬂuoride, 1 mM
iodoacetamide, and 5 g/ml of pepstatin A). Brieﬂy, the digested
samples and standards (C2C peptide) were preincubated with the
monoclonal antibody (C2C) overnight at 4C. The 50 ml of pre-
incubated solutions were transferred to 96 well plates coated with
the C2C peptide-KLH conjugate. Subsequently, after washing, 50 ml/
well of goat anti-mouse immunoglobulin labeled with alkaline
phosphatase (Zymed diluted 1/1000 with PBS, 1% bovine serum
albumin and 0.1% Tween 20, pH 7.2) was added to eachwell and the
plates were incubated for 1 h at 37C. After further washing, 50 ml/
well of disodium p-nitrophenyl phosphate (0.5 mg/ml in 1 M
diethanolamine buffer, pH 9.8) were added to each well. The
absorbance was read at 405 nm. The concentration of the C2C
epitope in each sample was determined from a log/linear plot of
concentration (ng/ml) vs corrected absorbance (sample absorbance
less mean of nonspeciﬁc binding absorbance).
Quantitation of KS
KS is a major component of aggrecan in adult articular cartilage.
To 150 ml of each sample, 10 ml of Keratanase II (0.001 units/ml;
Seikagaku Corporation, Tokyo, Japan) and 25 ml of sodium acetate
buffer (100 mM, pH 6.0) were added. The mixture was incubated at
37C for 3 h. and then ultraﬁltered using an Ultrafree C3GC system
(molecular size cutoff 10,000; JapanMillipore Ltd., Tokyo, Japan). The
ultraﬁltrate, which contains disaccharides Galb1-4GlcNac(6S) and
Gal(6S) b1-4GlcNAc(6S), each of which was derived from KS in the
sample, was analyzed by HPLC. The HPLC system used in this study
was constructed from two pumps (Model PU-2080; JASCO Corpo-
ration, Tokyo, Japan), and an auto-sampling injector (Model AS-
2059; JASCO Corporation, Tokyo, Japan), a stainless steel column
packed with polyamine-bound silica (YMC gel PA-120; YMC Ltd.,
Kyoto, Japan), a dry reaction bath (DB-5; Shimamura Instrument Co.,
Tokyo, Japan), a ﬂuoromonitor (Model FP-2025; JASCO Corporation),
and the Borwin-HSS software (JASCO Corporation, Tokyo, Japan). The
Galb1-4GlcNac(6S) and Gal(6S) b1-4GlcNAc(6S) in each sample were
eluted with a gradient of 0e100 mM sodium sulfate for 45 min at a
ﬂow rate of 0.5 ml/min. To the eluant from the column was added
100 mM sodium tetraborate buffer (pH 9.0) containing 1% 2-cyanoacetamide, at a ﬂow rate of 0.5 ml/min. The mixture was
passed through polyetheretherketone (PEEK) tubing (0.5 mm
diameter  10 m) set in a dry reaction bath thermostated at 145C
.The efﬂuent was monitored with a ﬂuoromonitor (excitation
331 nm, emission 383 nm). The area of each peak corresponding to
Galb1-4GlcNac(6S) and Gal(6S) b1-4GlcNac(6S) was calculated using
Borwin-HSS software and expressed as the concentration of KS-
disaccharides against the area of standard Galb1-4GlcNac(6S) and
Gal(6S) b1-4GlcNac(6S) (Seikagaku Corporation, Tokyo, Japan).
In each assay, puriﬁed KS derived from bovine cornea (Seika-
gaku Corporation, Tokyo, Japan) was used as a standard. The ratio of
the amount of KS applied for digested by Keratanase II to the total
amount of the disaccharides produced was calculated. The value
obtained was used as an “adjusting factor” for the calculation of the
KS content of the samples. The value of KS-derived disaccharides of
each sample was multiplied by the adjusting factor and total KS
value was determined. The intra and inter assay coefﬁcient of
variation was controlled within 6%.
Quantitation of Ddi-C4S and Ddi-C6S disaccharides of chondroitin
sulfate
Unsaturated Ddi-C4S and Ddi-C6S, primarily components of the
chondroitin sulfate chains of aggrecan although present on other
smaller proteoglycans, were also measured by HPLC. The concen-
trations were determined according to themethod of Shinmei et al.,
with minor modiﬁcations3. Each SF specimen (50 ml) was diluted
10-fold with distilled water and digested with chondroitinase ABC
(Seikagaku Corporation, Tokyo, Japan). After incubation at 37C for
2 h and ultraﬁltration, the ﬁltrate was analyzed by HPLC, and the
area of the peak corresponding to each unsaturated disaccharide
was calculated. The system used and the conditions were same as
described above for the detection of KS. The disaccharide standards
were purchased from Seikagaku Kougyou (Tokyo, Japan). The intra
and inter assay coefﬁcient of variation was controlled within 3e4%.
Statistical analysis
Data were analyzed using IBM SPSS Statistics version 19.0
software (SPSS Inc). A P-value 0.05 was considered statistically
signiﬁcant and P  0.1 was considered marginal.
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skewed, natural log transformation of biomarker data was per-
formed. The transformed data were visually inspected to meet the
assumption of normal distribution. Statistical analyses of biomarker
were performed using these log transformed values.
Initially, correlations between variables were estimated by
Spearman’s rank correlation test. Then, patients were divided into
four groups based on the total number of highly damaged cartilage
lesions present (0, 1, 2 and 3 or more). Fisher’s exact test was per-
formed to examine the group differences in the distribution of
dichotomized age, duration after injury, gender, biomarkers. To
dichotomize the values, upper or lower quartile values were used as
cutoff points. As for the number of high-grade cartilage lesions, the
upper quartile (3 or more) was deﬁned as a cutoff point. The
presence of three or more high-grade lesions was deﬁned as
the presence of multi high-grade cartilage lesions.
Finally, logistic regression analyses were conducted to conﬁrm
the independent impacts of variables on the presence of multi
high-grade cartilage lesions. Variables to be included in the model
to adjust for potential confounders were determined by the
method of Shrier and Platt22; basically, variables which showed
signiﬁcant associations with the outcome. Odds ratios for the
dichotomized and continuous variables for the presence of multi
high-grade lesions were examined respectively.
Furthermore, we estimated combined impacts of biomarkers on
the presence of multi high-grade cartilage lesions. Based on the
dichotomized levels of biomarkers, the subjects were divided into
four groups. Three dummy variables were constructed, and odds
ratios were derived compared to the group with none of the sug-
gested risk.
Results
The characteristics of the patients with ACL injured knees
The characteristics of the 108 patients studied are shown in
Table I. None of the patients exhibited radiographic evidence of
knee OA based on radiographic Kellgren and Lawrence grading and
examination of joint space and subchondral bone.
Findings from arthroscopic evaluations of articular cartilages and
menisci
A summary of the arthroscopic evaluations is shown in Fig. 1.
High-grade articular cartilage damage (Grade IIeIV) was mostTable I
Characteristics of study participants (N ¼ 108)
Variables Unit
Age Year Mean (SD) 26.4 (8.1)
Duration after injury Month Mean (SD) 23.8 (36.0)
Male/female N 72/36
Total number with high-grade damage
Cartilage N (%) 74 (68.5)
Meniscus N (%) 63 (58.3)
Biomarker
C2C ng/ml Median (IQR) 9.8 (5.8e13.5)
Ddi-C6S nmol/ml Median (IQR) 70.2 (54.5e90.0)
Ddi-C4S nmol/ml Median (IQR) 17.0 (13.2e21.3)
KS mg/ml Median (IQR) 12.1 (9.9e17.6)
C2C, cleavage neoepitope of type II collagen by collagenase; Ddi-C6S, disaccharide of
chondroitin-6-sulfate; Ddi-C4S, disaccharide of chondroitin-4-sulfate; IQR, inter-
quartile range.
Number of high-grade cartilage lesion is the total number of articular sites with
high-grade cartilage damage Outerbridge grades II, III, or IV. Number of high-grade
meniscal lesion is the total number of menisci with complete meniscal tear.frequently found on the MFC (n ¼ 49, 45%) followed by the LTP
(n ¼ 40, 37%). A total of 31.5% patients had no high-grade lesions in
any cartilage site. High-grade meniscal lesions (complete meniscal
tear) were present in the medial (17.6%), or lateral (23.1%) meniscus
or in both menisci (17.6%). A total of 41.7% patients had no high-
grade meniscal lesions.
Correlations between clinical variables, biomarkers and
arthroscopic evaluations
Table II shows Spearman’s rank order correlation coefﬁcients for
the total number of high-grade cartilage and meniscal lesions in
relation to clinical and biomarker variables. Total counts of high-
grade cartilage lesions showed signiﬁcant positive correlations
with age, duration after injury, C2C and negatively with KS. Gender,
Ddi-C4S and Ddi-C6S were not correlated with the number of high-
grade cartilage lesions. Ddi-C4S and Ddi-C6S were negatively
correlated with duration after injury. There was no variable which
showed a signiﬁcant correlation with the number of high-grade
meniscal lesions.
Table III shows Spearman’s rank order correlation coefﬁcients
for the grades of cartilage lesions in the six articular surface sites in
relationship to the number of high-grade meniscal lesions, as well
as clinical and biomarker variables. There were signiﬁcant corre-
lations with the total numbers of high-grade cartilage lesions
(r¼ 0.45 for LFC to 0.70 for MFC) but not with the numbers of high-
grade meniscal lesions (r ¼ 0.03 for MFC to 1.53 for patella). Age
was positively correlated with the cartilage lesion grade in all sites
(r ¼ 0.25 for LTP to 0.43 for MTP) except for LFC. Biomarker C2C
was positively correlated with lesion grade in the LFC, LTP and
marginally with that of MFC. KS was negatively correlated with
lesion grade ofMFC, LTP, patella andmarginally with that of patellar
groove (PG). Gender, Ddi-C4S and Ddi-C6S were not correlatedwith
the cartilage damage grade in any site.
Relationship of number of patients with high-grade cartilage lesions
to proportion of patients with deﬁned clinical and biomarker
parameters
The prevalence of patients’ characteristics deﬁned by the upper
or lower quartiles of the clinical variables and biomarkers in rela-
tionship to the number of high-grade cartilage lesions per joint is
shown in Table IV. Analyses were by Fisher’s exact test which
revealed consistent results with Spearman’s rank correlation. There
was an increase in the number of high-grade cartilage lesions with
age 32 years, duration after injury 24 month, C2C 13.5 ng/ml,
and KS 9.90 mg/ml.
Independent impacts of clinical variables and biomarkers on the
presence of multi high-grade cartilage lesions
Table V summarizes the impacts of age, duration after injury,
C2C and KS on the presence of multi high-grade cartilage lesions
per joint (three or more) using logistic regression analysis. Model 1
included the designated variable alone as an independent variable.
Age was added in Model 2, and all variables were entered simul-
taneously in Model 3 to adjust each other. All independent vari-
ables were tested in a binary manner and continuously.
Age and KS showed consistent signiﬁcant associations with the
presence of multi high-grade cartilage lesion even whether they
were entered as dichotomized or continuous variables. C2C was not
signiﬁcantly associated with the presence of multi high-grade
cartilage lesion when it was entered alone in Model 1. Only
marginally signiﬁcant ORs were observed after controlling for age
and KS in Model 3.
Table II
Spearman’s rank order correlation coefﬁcient between the total number of high-grade cartilage lesion, clinical variables and biomarkers
Variables Number of high-grade
cartilage lesions
Number of high-grade
meniscal lesions
Age Duration Sex C2C Ddi-C6S Ddi-C4S
Number of high-grade
meniscal lesions
r 0.03 1
P-value 0.76
Age r 0.39 0.03 1
P-value <0.001 0.78
Duration after injury r 0.32 0.15 0.20 1
P-value 0 0.13 0.04
Sex (male/female) r 0.05 0.10 0.15 0.22 1
P-value 0.63 0.28 0.13 0.03
C2C r 0.27 0.10 0.01 0.03 0.003 1
P-value 0.01 0.29 0.95 0.8 0.97
Ddi-C6S r 0.11 0.09 0.17 0.25 0.06 0.13 1
P-value 0.26 0.35 0.08 0.01 0.55 0.19
Ddi-C4S r 0.01 0.001 0.05 0.44 0.14 0.24 0.78 1
P-value 0.9 0.99 0.6 <0.001 0.15 0.01 <0.001
KS r 0.29 0.03 0.09 0.08 0.17 0.21 0.64 0.42
P-value 0 0.79 0.34 0.4 0.08 0.03 <0.001 <0.001
C2C; cleavage neoepitope of type II collagen by collagenase.
Number of high-grade cartilage lesions represents the total number of lesions with Outerbridge grades II, III or IV Number of high-grade meniscal lesions represents the total
number of menisci with complete tears.
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examined. Odds ratio (OR) of “high C2C (upper quartile) with low
KS (lower quartile)”, “normal non-elevated C2C with low KS (lower
quartile)”, and “high C2C with normal non-reduced KS” to “normal
non-elevated C2C with normal non-reduced KS” groups for the
presence of multi high-grade cartilage damage are presented in
Table VI. ORs of all groups were above 1.0 compared to the “normal
C2C” and “normal KS” groups (reference groups). The combined
impact of high C2C with low KS on the presence of the multi high-
grade cartilage damage exceeded the product of ORs for “high C2C
with normal KS” and “normal C2C with low KS”; unadjusted OR
was 14.40 (95% CI ¼ 1.35e153.0) and the OR controlling for age and
duration after injury was 22.75 (95% CI ¼ 1.95e265.9). This clearly
points to the value of using a combination of biomarkers and
deﬁned quartiles in studies of this kind.
Discussion
We clearly show that a combination of deﬁned ranges of the C2C
and KS biomarkers is strongly associated with the presence of
multi-high grade cartilage lesions, independently of clinicalTable III
Spearman’s rank order correlation coefﬁcients of the grades of articular cartilage lesions
Variables MFC
Number of high-grade cartilage lesions r 0.70
P-value <0.001
Number of high-grade meniscal lesions r 0.00
P-value 0.97
Age r 0.28
P-value <0.001
Duration after injury r 0.35
P-value <0.001
Sex (male/female) r 0.04
P-value 0.68
C2C r 0.18
P-value 0.06
Ddi-C6S r 0.09
P-value 0.35
Ddi-C4S r 0.06
P-value 0.57
KS r 0.21
P-value 0.03
C2C, cleavage neoepitope of type II collagen by collagenase.
Cartilage damage grade was based on Outerbridge classiﬁcation. Number of high-gradevariables, in patients after ACL rupture that lack any radiographic
changes.
The changes in proteoglycan glycosaminoglycans seen here are
reﬂective of earlier analyses of osteoarthritic compared to normal
articular cartilages. In OA articular cartilages there is a loss of the
proteoglycan aggrecan, the principal source of KS, and a net loss of
KS23,24. This is accompanied by increased aggrecan synthesis25. But
themolecules that are made are more fetal in character in that their
glycosaminoglycan content is deﬁcient in KS and enriched in
chondroitin-4-sulfate over chondroitin-6-sulfate in contrast to
normal articular cartilages24e26. These earlier ﬁndings, from ana-
lyses of articular cartilages, help explain the signiﬁcant association
of the lower quartile of KS with multi-high grade cartilage lesions
(Tables II and V) and the changes in chondroitin-4- and 6-sulfate
with duration after injury (Table II).
The increase of the C2C biomarker, reﬂective of increased
collagenase cleavage of cartilage type II collagen, corresponded
with the increased number of high-grade cartilage lesions (Table II).
This is in agreement with the increase in type II collagen cleavage
noted in articular cartilage removed at surgery for ACL recon-
struction following recent joint injury8,9 and in focal articularwith clinical variables, biomarkers and numbers of high-grade meniscal lesions
LFC MTP LTP Patellar PG
0.45 0.61 0.73 0.54 0.50
<0.001 <0.001 <0.001 <0.001 <0.001
0.07 0.10 0.19 0.19 0.13
0.47 0.30 0.048 0.046 0.17
0.04 0.42 0.25 0.40 0.35
0.68 <0.001 0.009 <0.001 <0.001
0.15 0.36 0.12 0.23 0.20
0.13 <0.001 0.21 0.01 0.04
0.10 0.02 0.05 0.06 0.04
0.30 0.81 0.61 0.51 0.66
0.26 0.01 0.26 0.07 0.06
0.007 0.91 0.006 0.46 0.55
0.03 0.05 0.04 0.16 0.10
0.78 0.61 0.65 0.10 0.31
0.00 0.08 0.08 0.11 0.05
0.99 0.40 0.41 0.27 0.61
0.10 0.13 0.30 0.37 0.19
0.30 0.17 <0.001 <0.001 0.05
meniscal lesions is the total number of menisci with complete tears.
Table IV
Prevalence of high-grade cartilage lesions in total patient population: relationship to clinical and biomarker variables
Variables Total Number of high-grade cartilage lesion *P-value P-value
for trend
0 1 2 3
N ¼ 108 N ¼ 34 N ¼ 26 N ¼ 20 N ¼ 28
N % N % N % N % N %
Age 32 Years Upper quartile 27 (25.0) 1 (2.9) 6 (23.1) 7 (35.0) 13 (46.4) <0.001 <0.001
Duration after injury 24 Months Upper quartile 30 (27.8) 3 (8.8) 10 (38.5) 6 (30.0) 11 (39.3) 0.002 0.02
Sex Female 36 (0.0) 11 (0.0) 7 (0.0) 8 (0.0) 10 (0.0) 0.30 0.67
Biomarker
C2C 13.5 ng/ml Upper quartile 27 (25.0) 4 (11.8) 6 (23.1) 8 (40.0) 9 (32.1) 0.01 0.04
Ddi-C6S 54.5 nmol/ml Lower quartile 26 (24.1) 10 (29.4) 5 (19.2) 7 (35.0) 5 (17.9) 0.15 0.51
Ddi-C4S 21.3 nmol/ml Upper quartile 23 (21.3) 9 (26.5) 5 (19.2) 5 (25.0) 8 (28.6) 0.37 0.77
KS 9.90 mg/ml Lower quartile 27 (25.0) 6 (17.6) 6 (23.1) 3 (15.0) 12 (42.9) 0.01 0.06
Cartilage damage grade was based on Outerbridge classiﬁcation. Number of high-grade cartilage lesions is the total number with cartilage damage of Outerbridge grades II, III
or IV C2C; cleavage neoepitope of type II collagen by collagenase.
* P-value for the differences among categories deﬁned by the number of high-grade cartilage lesion was determined by Fisher’s exact test.
H. Yoshida et al. / Osteoarthritis and Cartilage 21 (2013) 831e838836cartilage lesions examined at autopsy10 and at arthroplasty11,12.
Unlike with lower quartile KS, multivariable regression analysis
failed to show a signiﬁcant association of upper quartile C2C with
multi-high grade cartilage lesion although it approached signiﬁ-
cance (P ¼ 0.07, Table V). Thus it was very interesting, that the
combination of upper quartile C2C and lower quartile KS provided a
very much stronger association than each biomarker alone
(Table VI) no doubt a consequence of the differences in turnover
between type II collagen and aggrecan discussed above.
These biomarker observations point to early joint changes after
injury in cartilage matrix turnover and composition of the kind
seen in clinically deﬁned OA. In addition to these changes in matrix
molecules, changes in pro-inﬂammatory cytokines, that can cause
these matrix changes1, have also been reported in this period
following acute phase of knee injury27e28.
Our ﬁndings conﬁrm an earlier report29 that higher grade
cartilage lesions are more commonly observed in older patients,
following ACL injury. We also noted that age was correlated with
arthroscopic cartilage damage grade in most sites (Table III). This
may relate to an increased susceptibility of older persons to pro-
gression of cartilage damage because of reduced cartilage repair
capacity. Importantly, the biomarkers C2C and KS, were associated
with multi-high grade cartilage lesions independently of age and
duration after injury.
Other recent arthritis studies15,30 have reported on the value of
combining clinical information with biomarker analyses to maxi-
mize predictability of whether early pre-radiographic knee joint
damage is present in a population or if a given therapy is effective.Table V
Odds ratios for the presence of multi high-grade cartilage lesions by age, duration of inj
Model 1 Mod
OR Age
(95% CI) P-Value
Age <32 years 1.00 Reference
32 years 4.09 (1.60e10.5) 0.003
Continuous 1.09 (1.03e1.15) 0.001
Duration <24 months 1.00 Reference 1.00
24 months 2.08 (0.83e0.52) 0.12 1.85
Continuous 1.01 (0.99e1.02) 0.11 1.00
C2C <13.5 ng/ml 1.00 Reference 1.00
13.5 ng/ml 1.63 (0.63e4.22) 0.31 1.83
Continuous* 1.38 (0.68e2.81) 0.37 1.49
KS >9.90 mg/ml 1.00 Reference 1.00
9.90 mg/ml 3.25 (1.28e8.28) 0.01 3.01
Continuous* 0.10 (0.02e0.45) 0.03 0.13
The presence of multi high-grade cartilage lesions is deﬁned as three or more articular s
* Log transformed.The addition of more clinical information, including symptoms
(pain, Western Ontario and McMaster Universities Arthritis Index
(WOMAC) score) and Body Mass Index may improve predictability
in studies such as ours.
Meniscal injury is an important risk factor for knee OA31,32.
Englund et al. have shown that there is a 6-fold increased relative
risk for the development of radiographic OA after total meniscec-
tomy, comparedwith unoperated controls32. In our study, increased
meniscal damage was clearly not associated with damage to artic-
ular cartilage at this early point in time nor was there any evidence
that it was related to any changes in biomarker levels. Thus cartilage
and meniscal damage would not appear to have occurred at the
same or similar times during the period of this study.
The main component of the meniscus is type I collagen. It is also
very deﬁcient in glycosaminoglycans compared to articular carti-
lage33. It therefore makes sense that increased levels of C2C and
altered glycosaminoglycan levels reﬂect the turnover of the extra-
cellular matrix of articular cartilage rather than that of the
meniscus, damage to which is thought to often proceed damage to
articular cartilage34.
There are some limitations to this study. We focused on pa-
tients with pre-radiographic structural damage after ACL injury.
Therefore, most of patients had 500 mle1 ml of SF with which we
could conduct our assays. However, patients fromwhomwe could
not collect the SF were excluded. Thus there is a possibility that
patients with less cartilage damage could have been excluded. Our
study is also a cross-sectional study. There was no evidence when
cartilage damage occurred with respect to the initial time of ACLury, and the levels of C2C and KS
el 2 Model 3
adjusted OR Multivariable adjusted OR
(95% CI) P-Value (95% CI) P-Value
1.00 Reference
3.67 (1.37e9.83) 0.010
1.08 (1.02e1.14) 0.012
Reference 1.00 Reference
(0.71e4.85) 0.21 2.28 (0.83e6.25) 0.108
(0.99e1.02) 0.27 1.01 (1.00e1.02) 0.230
Reference 1.00 Reference
(0.67e5.00) 0.24 2.49 (0.85e7.27) 0.096
(0.70e3.17) 0.30 2.19 (0.94e5.12) 0.070
Reference 1.00 Reference
(1.11e8.15) 0.03 3.32 (1.19e9.24) 0.022
(0.03e0.59) 0.008 0.09 (0.02e0.43) 0.003
ites with cartilage damage of Outerbridge gradesII, III, or IV.
Table VI
Combined association of dichotomized levels of C2C and KS and the presence of multi high-grade cartilage lesions
Total Multi high-grade
cartilage lesion
Unadjusted model Age adjusted model Age þ duration
adjusted model
N N (%) OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
C2C < 13.5 ng/ml,
KS > 9.90 mg/ml
58 10 (17.2) 1.00 Reference 1.00 Reference 1.00 Reference
C2C  13.5 ng/ml,
KS > 9.90 mg/ml
23 6 (26.1) 1.69 (0.53e5.37) 0.37 1.69 (0.51e5.62) 0.40 1.83 (0.54e6.21) 0.33
C2C < 13.5 ng/ml,
KS  9.90 mg/ml
23 9 (39.1) 3.09 (1.05e9.08) 0.04 2.61 (0.82e8.33) 0.11 2.50 (0.77e8.10) 0.13
C2C  13.5 ng/ml,
KS  9.90 mg/ml
4 3 (75.0) 14.40 (1.35e153.0) 0.03 18.65 (1.63e212.7) 0.02 22.75 (1.95e265.9) 0.01
H. Yoshida et al. / Osteoarthritis and Cartilage 21 (2013) 831e838 837injury. Nor was there evidence of whether the damage progressed
after injury which is possible. Further longitudinal studies are
required to see if these biomarkers can predict progression of
cartilage damage.
We categorized the study population by the number of high-
grade cartilage lesions in a given knee. Yet identical numbers of
these lesions did not reveal the same cartilage damage as different
sites were involved. But, as shown in Table III, the number of high-
grade cartilage lesions was associated with the degree of cartilage
damage (grade) in each site.
To demonstrate the independent impacts of C2C and KS on the
presence of high-grade cartilage damage, we used a logistic
regression model and presented the results as ORs. Even though it
is commonly used, there has been debate regarding the use of lo-
gistic regression in cross-sectional studies to estimate relative risks
when the prevalence of the outcome of interest is high35. Alter-
natives should therefore be tested36.
In conclusion, use of the combination of deﬁned ranges (quar-
tiles) of the biomarkers C2C and KS clearly offers an opportunity to
help identify patients with pre-radiographic high-grade articular
cartilage lesions which may or may not lead to the development
over time of radiographic OA. This may be of value in future clinical
studies. Our ﬁndings clearly point to the value of using a combi-
nation of biomarkers and deﬁned quartiles thereof in studies of this
kind.
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